Actively Recruiting
Meu-cinn for Gastric Mucosal Health in Adults With Functional Dyspepsia
Led by Pusan National University Yangsan Hospital · Updated on 2025-06-03
100
Participants Needed
1
Research Sites
56 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial aims to determine whether Meu-cinn promotes gastric mucosal health in adults with functional dyspepsia and to assess its safety. The main questions are: * Does Meu-cinn promote gastric mucosal health in participants? * What side effects occur when participants take Meu-cinn?
CONDITIONS
Official Title
Meu-cinn for Gastric Mucosal Health in Adults With Functional Dyspepsia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 19 to 70 years
- Diagnosed with functional dyspepsia based on Rome IV criteria
You will not qualify if you...
- Patients needing immediate drug treatment for gastrointestinal symptoms
- History of hypersecretory gastric disorders like Zollinger-Ellison syndrome
- Received Helicobacter pylori eradication therapy within 4 weeks before the study
- Taken NSAIDs, steroids, antibiotics, aspirin, antithrombotic agents, or acid suppressants within the last month
- History of upper gastrointestinal surgery, stricture, bleeding, or procedures like esophageal dilation or mucosal resection in the last year
- Presence of active or healing gastric or duodenal ulcers, reflux esophagitis (LA grade A or higher), or malignant tumors found by endoscopy within the last 6 months
- Uncontrolled hypertension (resting BP ≥160/100 mmHg)
- Uncontrolled diabetes (fasting glucose ≥160 mg/dL)
- Creatinine levels ≥ 2 times the upper limit of normal
- Elevated liver enzymes (AST or ALT ≥ 2 times the upper limit of normal)
- Alcohol abuse
- Taking medications for psychiatric disorders (except intermittent sleep disorder medication)
- Pregnant or breastfeeding women or planning pregnancy during the trial
- Allergies to any components of the study foods
- Participated or plans to participate in another drug clinical trial within the last month
- Any other reason deemed unsuitable by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pusan National University Yangsan Hospital
Yangsan, South Korea, 50612
Actively Recruiting
Research Team
S
Sang Yeoup Lee, Professor, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here